Skip to main content

Cardiac stents to cost less (the hindu )


Cap on pricing will help patients facing cardiac emergency


With the government notifying all categories of cardiac stents under the Drug Price Control Order (DPCO) of 2013, heart patients going in for angioplasty could be spared of “exploitative” pricing.

The notification issued by the Department of Pharmaceuticals on Wednesday to the National Pharmaceutical Pricing Authority will now result in a new pricing regime for cardiac stents that will bring in a cap on the maximum retail price of cardiac devices. Bare metal stents, drug-eluting stents and bio-resorbable vascular scaffold or what is known as biodegradable stents would be brought under the DPCO.

The move would bring down the price of stents to less that Rs.15,000 for bare metal stents (BMS) and possibly between Rs.20,000 and Rs.25,000 for drug-eluting stents (DES), said Harikrishnan S., professor of Cardiology, Sree Chitra Tirunal Institute of Medical Sciences and Techno
The government had notified the price of stents for the Central Government Health Scheme (CGHS) three years ago at Rs.10,000 to Rs.12,000 for BMS and Rs.25,000 for DES. The new notification is likely to bring it down further, Prof. Harikrishnan said.

About 80 per cent of the stents used in angioplasties are drug-eluting stents. And these are priced in the range of Rs.75,000 to Rs.1.75 lakh, claiming better quality in design, metal, drug release or any other feature. However, there are no studies to prove that a particular stent is better, say medical researchers.

But the spurt in the demand for stents has resulted in many Indian manufacturers coming up with innovative designs, said K.M. Gopakumar, legal researcher and public health activist associated with the Third World Network. “I expect the health-care industry, manufacturers and the government to be embroiled in a battle on pricing,” he added.

A cap on pricing will definitely bring some comfort to the patient facing a cardiac emergency, said cardiologist P.P. Mohanan, who is also vice president of the Cardiological Society of India (CSI). “There are a range of cardiac stents and cardiologists prefer stents that give lesser chance of restenosis (redoing of angioplasty). Data show that drug eluting stents are better on that account,” said Dr. Mohanan, adding that it would not be fair to have a uniform price for all stents.

About 35,000 angioplasties were done in the State in 2015, with 25 per cent growth almost every year. The CSI estimates about 4 lakh to 4.2 lakh angioplasties a year in the country.
Labels:

Comments

Post a Comment

Popular posts from this blog

NGT terminates chairmen of pollution control boards in 10 states (downtoearth,)

Cracking the whip on 10 State Pollution Control Boards (SPCBs) for ad-hoc appointments, the National Green Tribunal has ordered the termination of Chairpersons of these regulatory authorities. The concerned states are Himachal Pradesh, Sikkim, Tamil Nadu, Uttarakhand, Kerala, Rajasthan, Telangana, Haryana, Maharashtra and Manipur. The order was given last week by the principal bench of the NGT, chaired by Justice Swatanter Kumar. The recent order of June 8, 2017, comes as a follow-up to an NGT judgment given in August 2016. In that judgment, the NGT had issued directions on appointments of Chairmen and Member Secretaries of the SPCBs, emphasising on crucial roles they have in pollution control and abatement. It then specified required qualifications as well as tenure of the authorities. States were required to act on the orders within three months and frame Rules for appointment [See Box: Highlights of the NGT judgment of 2016 on criteria for SPCB chairperson appointment]. Having
Post a Comment
Click Here To Read more »

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo
1 comment
Click Here To Read more »

SC asks Centre to strike a balance on Rohingya issue (.hindu)

Supreme Court orally indicates that the government should not deport Rohingya “now” as the Centre prevails over it to not record any such views in its formal order, citing “international ramifications”. The Supreme Court on Friday came close to ordering the government not to deport the Rohingya. It finally settled on merely observing that a balance should be struck between humanitarian concern for the community and the country's national security and economic interests. The court was hearing a bunch of petitions, one filed by persons within the Rohingya community, against a proposed move to deport over 40,000 Rohingya refugees. A three-judge Bench, led by Chief Justice of India Dipak Misra, began by orally indicating that the government should not deport Rohingya “now”, but the government prevailed on the court to not pass any formal order, citing “international ramifications”. With this, the status quo continues even though the court gave the community liberty to approach i
1 comment
Click Here To Read more »